Amador Bioscience is a global leading translational & clinical research CRO, and has established sites in China, the US, and Europe.
As a leading partner for successful innovative drug R&D, Amador Bioscience drives the development of new drugs with clinical pharmacology, providing the complete chain of clinical development services in line with international standards. The services include the development and approval process from pre-clinical to NDA/BLA. We scientifically “choose dose, choose target, choose patient,” and utilize global implementation of quality standards to enhance the success rate of new drugs.